AMGN
AMGEN
Stock NASDAQ – Stock Market Prices, News & Analysis
Amgen is a global leader in biotechnology, developing innovative treatments for serious diseases in various areas such as oncology, cardiology, and neurology.
AMGEN
AMGN
Amgen is a global leader in biotechnology, developing innovative treatments for serious diseases in various areas such as oncology, cardiology, and neurology.
Price history of AMGEN
Price history of AMGEN
Performance & Momentum
Strategic Analysis
AMGEN • 2026
Amgen positions itself as a key player in American biotechnology, specializing in the development of innovative treatments for serious conditions in oncology, cardiology, and neurology. Its model is based on a strong capacity for innovation combined with a broad therapeutic diversification, ensuring a stable presence in high value-added segments.
Strengths
- Recognized leadership in several major therapeutic areas such as oncology and cardiology
- Sustained innovation capacity with a robust pipeline promoting medium- to long-term growth
- Diversified portfolio that reduces dependence on a single market segment
Weaknesses
- Intense competition in biotechnology, particularly from emerging innovative players
- Regulatory risks and the high cost of pharmaceutical development
Momentum
Amgen's momentum is strong and improving, supported by a positive trend across several time horizons. This dynamic reflects market confidence in its operational outlook and medium-term growth potential, with no recent specific events disrupting this trajectory.
Similar stocks to AMGEN
Take control
of your investments
Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.
- Real-time multi-portfolio tracking
- AI analysis of your positions
- Counter your cognitive biases
